R.J. Reynolds Tobacco Company v. United States Food and Drug Administration

845 F. Supp. 2d 266, 40 Media L. Rep. (BNA) 1473, 2012 U.S. Dist. LEXIS 26257
CourtDistrict Court, District of Columbia
DecidedFebruary 29, 2012
DocketCivil Action No. 2011-1482
StatusPublished
Cited by8 cases

This text of 845 F. Supp. 2d 266 (R.J. Reynolds Tobacco Company v. United States Food and Drug Administration) is published on Counsel Stack Legal Research, covering District Court, District of Columbia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
R.J. Reynolds Tobacco Company v. United States Food and Drug Administration, 845 F. Supp. 2d 266, 40 Media L. Rep. (BNA) 1473, 2012 U.S. Dist. LEXIS 26257 (D.D.C. 2012).

Opinion

*268 MEMORANDUM OPINION

RICHARD J. LEON, District Judge.

Plaintiffs in this case (“plaintiffs”) are five tobacco companies, which include the second-, third-, and fourth-largest tobacco manufacturers and the fifth-largest cigarette manufacturer in the United States. Complaint (“Compl.”), Aug. 16, 2011, ¶¶ 8-12 [Dkt. # 1]. In June 2011, defendant United States Food and Drug Administration (“FDA”) published a Final Rule requiring (among other things) the display of nine new textual warnings — along with certain graphic images 1 such as diseased lungs and a cadaver bearing chest staples on an autopsy table — on the top 50% of the front and back panels of every cigarette package manufactured and distributed in the United States on or after September 22, 2012. See FDA, Required Warnings for Cigarette Packages and Advertisements, 76 Fed. Reg. 36,628 (June 22, 2011) (“the Rule”); see also Mem. in Supp. of Pis.’ Mot. for Summ. J. and Permanent Inj. (“Pis.’ Mot.”), Aug. 19, 2011, at 3-5 [Dkt. # 10]. Alleging that the Rule violates the First Amendment and the Administrative Procedure Act (“APA”), 5 U.S.C. §§ 553(b)(3), 705, 706(2)(A), see Compl. ¶¶ 5-6, plaintiffs moved for a preliminary injunction on August 19, 2011, enjoining the enforcement of the Rule until fifteen months after resolution of plaintiffs’ claims on the merits. See Pis.’ Mot. at iii. As such, plaintiffs raised for the first time in our Circuit the question of whether the FDA’s new and mandatory graphic images, when combined with certain textual warnings on cigarette packaging, are unconstitutional under the First Amendment. The Court granted plaintiffs’ motion on November 7, 2011. See R.J. Reynolds Tobacco Co. v. FDA, 823 F.Supp.2d 36, 39, n. 1 (D.D.C.2011). Since then both parties have moved for summary judgment on the same issues. 2 Upon review of the pleadings, oral argument, the entire record, and the applicable law, the Court concludes that these mandatory graphic images violate the First Amendment by unconstitutionally compelling speech. For that and the other reasons stated herein, the Court GRANTS plaintiffs’ Motion for Summary Judgment and DENIES the Cross-Motion for Summary Judgment. 3

BACKGROUND 4

I. Statutory and Regulatory History

A. The Act

The Family Smoking Prevention and Tobacco Control Act (“Act” or “the Act”), Pub.L. No. 111-31, 123 Stat. 1776 (2009), *269 which President Obama signed into law on June 22, 2009, gives the FDA the authority to regulate the manufacture and sale of tobacco products, including cigarettes. Mem. in Support of Defs.’ Mot. for Summ. J. and in Opp’n to Pis.’ Mot. for Summ. J. (“Defs.’ Opp’n”), Oct. 21, 2011, at 1 [Dkt. #34], Pursuant to that authority, Congress directed the Secretary of the U.S. Department of Health and Human Services (“the Secretary”) to “issue regulations that require color graphics depicting the negative health consequences of smoking.” 5 See Pub.L. No. 111-31, § 201(a) (amending 15 U.S.C. § 1333(d)); Compl. ¶ 31; Defs.’ Opp’n at 1. In addition, Congress required all cigarette packages manufactured, packaged, sold, distributed, or imported for sale or distribution within the United States to bear’ one of the following nine textual warnings:

“WARNING: Cigarettes are addictive.
WARNING: Tobacco smoke can harm your children.
WARNING: Cigarettes cause fatal lung disease.
WARNING: Cigarettes cause cancer.
WARNING: Cigarettes cause strokes and heart disease.
WARNING: Smoking during pregnancy can harm your baby.
WARNING: Smoking can kill you.
WARNING: Tobacco smoke causes fatal lung disease in nonsmokers.
WARNING: Quitting smoking now greatly reduces serious risks to your health.” Act § 201(a) (amending 15 U.S.C. § 1333(a)(1)).

Congress required that these new textual warnings and graphic images occupy the top 50% of the front and back panels of all cigarette packages, Act § 201(a) (amending 15 U.S.C. § 1333(a)(2)), and the top 20% of all printed cigarette advertising, id. (amending 15 U.S.C. § 1333(b)(2)). It gave the FDA “24 months after the date of enactment” of the Act to issue regulations implementing the requirements of Section 201. Act § 201(a) (amending 15 U.S.C. § 1333(d)); Compl. ¶ 33. Finally, under the Act, the new textual warnings and graphic-image labels (and the related requirements) were scheduled to take effect 15 months after issuance of the Rule. Act § 201(b) (note on amending 15 U.S.C. § 1333).

B. The Rule

1. Proposed Rule

On November 12, 2010, the FDA submitted for public comment a Proposed Rule unveiling 36 graphic color images that could be displayed with the 9 new textual warnings created by Congress. 6 Required Warnings for Cigarette Packages and Advertisements, 75 Fed. Reg. 69,524; 69,534-69,535 (Nov. 12, 2010) (to be codified at 21 C.F.R. Part 1141); Compl. ¶¶ 36, 38; Defs.’ Opp’n at 10-11. In addition, the Proposed Rule required cigarette packaging and advertising to include “a reference to a smoking cessation assistance resource” and set forth related requirements for what that resource must *270 provide. 75 Fed. Reg. 69,564 (proposing 21 C.F.R. § 1141.16(a)); Compl. ¶ 39. Finally, as part of its preliminary benefits analysis, the FDA estimated that “the U.S. smoking rate will decrease by 0.212 percentage points” as a result of the Proposed Rule, 75 Fed. Reg. 69,543 (emphasis added), a statistic the FDA admits is “in general not statistically distinguishable from zero.” 7 Id. at 69,546; see also Compl. ¶ 41.

2. Final Rule

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Am. Acad. of Pediatrics v. U.S. Food & Drug Admin.
330 F. Supp. 3d 657 (District of Columbia, 2018)
Patterson v. United States of America
999 F. Supp. 2d 300 (District of Columbia, 2013)
Demarest v. City of Leavenworth
876 F. Supp. 2d 1186 (E.D. Washington, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
845 F. Supp. 2d 266, 40 Media L. Rep. (BNA) 1473, 2012 U.S. Dist. LEXIS 26257, Counsel Stack Legal Research, https://law.counselstack.com/opinion/rj-reynolds-tobacco-company-v-united-states-food-and-drug-administration-dcd-2012.